Session | ||
P450 Drug Design and targeting: Symposia 7 P450 Drug Design and targeting
Session Topics: 7. Cytochrome P450 Drug Design and targeting
| ||
Presentations | ||
10:00am - 10:30am
Non-Steroidal Inhibitors of CYP17A1 for Prostate Cancer Therapy 10:30am - 11:00am
CYP46A1 as a Pharmacologic Target for Alzheimer’s Disease and Other Brain Disorders Presentations of the Symposium CYP46A1 as a Pharmacologic Target for Alzheimer’s Disease and Other Brain Disorders 11:00am - 11:15am
Targeting steroidogenic P450s with natural compounds and nanoparticles for cancer and endocrine disorders 11:15am - 11:30am
Abiraterone-derived dual inhibitor targeting CYP17A1 and HDAC6 as a novel strategy to overcome temozolomide resistance in glioblastoma 11:30am - 12:00pm
Selective chemical inhibition of CYP3A4 and CYP3A5 |